The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126641891 12664189 1 I 20160809 20160818 20160818 EXP CH-GLAXOSMITHKLINE-CH2016GSK119198 GLAXOSMITHKLINE CALMY A, VAN DELDEN C, GIOSTRA E, JUNET C, BRANDT LR, YERLY S ET AL. HIV-POSITIVE-TO-HIV-POSITIVE LIVER TRANSPLANTATION. AMERICAN JOURNAL OF TRANSPLANTATION. 2016;16:2473-2478 53.00 YR M Y 0.00000 20160818 OT CH CH

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126641891 12664189 1 PS LAMIVUDINE. LAMIVUDINE 1 UNK 20564
126641891 12664189 2 SS ZIDOVUDINE. ZIDOVUDINE 1 UNK 0
126641891 12664189 3 SS Dolutegravir DOLUTEGRAVIR 1 UNK U 0
126641891 12664189 4 SS TACROLIMUS. TACROLIMUS 1 UNK U 0
126641891 12664189 5 SS Nelfinavir mesylate NELFINAVIR MESYLATE 1 UNK 0
126641891 12664189 6 SS STAVUDINE. STAVUDINE 1 UNK 0
126641891 12664189 7 SS INDINAVIR INDINAVIR 1 UNK 0
126641891 12664189 8 SS RILPIVIRINE RILPIVIRINE 1 UNK U 0
126641891 12664189 9 SS RILPIVIRINE RILPIVIRINE 1 UNK U 0
126641891 12664189 10 SS RILPIVIRINE RILPIVIRINE 1 UNK U 0
126641891 12664189 11 SS ZALCITABINE ZALCITABINE 1 UNK 0
126641891 12664189 12 C ABACAVIR. ABACAVIR 1 UNK 0
126641891 12664189 13 C TENOFOVIR DISOPROXIL FUMARATE. TENOFOVIR DISOPROXIL FUMARATE 1 UNK 0
126641891 12664189 14 C TENOFOVIR DISOPROXIL FUMARATE. TENOFOVIR DISOPROXIL FUMARATE 1 UNK 0
126641891 12664189 15 C TENOFOVIR DISOPROXIL FUMARATE. TENOFOVIR DISOPROXIL FUMARATE 1 UNK 0
126641891 12664189 16 C TENOFOVIR DISOPROXIL FUMARATE. TENOFOVIR DISOPROXIL FUMARATE 1 UNK 0
126641891 12664189 17 C EFAVIRENZ EFAVIRENZ 1 UNK 0
126641891 12664189 18 C EMTRICITABINE EMTRICITABINE 1 UNK 0
126641891 12664189 19 C EMTRICITABINE EMTRICITABINE 1 UNK 0
126641891 12664189 20 C EMTRICITABINE EMTRICITABINE 1 UNK 0
126641891 12664189 21 C DIDANOSINE. DIDANOSINE 1 UNK 0
126641891 12664189 22 C RALTEGRAVIR. RALTEGRAVIR 1 UNK 0
126641891 12664189 23 C VALGANCICLOVIR. VALGANCICLOVIR 1 0
126641891 12664189 24 C SULFAMETHOXAZOLE AND TRIMETHOPRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 0
126641891 12664189 25 C ENFUVIRTIDE ENFUVIRTIDE 1 UNK 0
126641891 12664189 26 C MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 UNK 0
126641891 12664189 27 C BASILIXIMAB BASILIXIMAB 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126641891 12664189 1 HIV infection
126641891 12664189 2 HIV infection
126641891 12664189 3 Antiretroviral therapy
126641891 12664189 4 Immunosuppression
126641891 12664189 5 Antiviral treatment
126641891 12664189 6 HIV infection
126641891 12664189 7 HIV infection
126641891 12664189 8 Antiviral treatment
126641891 12664189 11 HIV infection
126641891 12664189 12 Antiviral treatment
126641891 12664189 13 Antiviral treatment
126641891 12664189 17 Antiviral treatment
126641891 12664189 18 Antiviral treatment
126641891 12664189 21 Antiviral treatment
126641891 12664189 22 Antiviral treatment
126641891 12664189 23 Prophylaxis against transplant rejection
126641891 12664189 24 Prophylaxis against transplant rejection
126641891 12664189 25 Antiretroviral therapy
126641891 12664189 26 Immunosuppression
126641891 12664189 27 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126641891 12664189 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126641891 12664189 Antiviral drug level above therapeutic
126641891 12664189 Drug level decreased
126641891 12664189 Drug resistance
126641891 12664189 Pathogen resistance
126641891 12664189 Viral mutation identified

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126641891 12664189 1 1997 2001 0
126641891 12664189 2 1992 0
126641891 12664189 3 201601 0
126641891 12664189 4 201510 0
126641891 12664189 5 1998 2001 0
126641891 12664189 6 1997 2001 0
126641891 12664189 7 1997 1998 0
126641891 12664189 8 2013 0
126641891 12664189 9 201510 0
126641891 12664189 10 201601 0
126641891 12664189 11 1992 0
126641891 12664189 12 2002 0
126641891 12664189 13 2003 0
126641891 12664189 14 2013 0
126641891 12664189 15 201510 0
126641891 12664189 16 201601 0
126641891 12664189 17 2002 0
126641891 12664189 18 2013 0
126641891 12664189 19 201510 0
126641891 12664189 20 201601 0
126641891 12664189 21 2002 2003 0
126641891 12664189 22 201510 0
126641891 12664189 25 201510 0
126641891 12664189 26 201510 0